Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert T. Foster currently holds 50,470 shares of Hepion Pharmaceuticals, Inc. (HEPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert T. Foster has been a net buyer of HEPA stock. They have purchased $97.1K and sold $0 worth of shares.
Robert T. Foster's most recent insider trade was on Sep 18, 2023, when they purchased 1,600 shares at $5.60 per share.
Robert T. Foster serves as Executive at Hepion Pharmaceuticals, Inc. (HEPA). They have executed 6 insider transactions totaling $97.1K over their tenure at the company.
Robert T. Foster holds the position of Executive at Hepion Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Robert T. Foster has shown a buying trading pattern, with $97.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert T. Foster was on Feb 18, 2021, when they purchased $40.0K worth of HEPA shares. This transaction involved 20,000 shares at $2.00 per share.
Robert T. Foster currently owns 50,470 shares of Hepion Pharmaceuticals, Inc. (HEPA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert T. Foster's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert T. Foster has 6 Form 4 filings on record as an insider at Hepion Pharmaceuticals, Inc..
Set alerts for Robert T. Foster and 40,000+ other insiders.